estrogens, conjugated (USP) 1.25 MG Oral Tablet

RxCUI
197662
RxNorm name
estrogens, conjugated (USP) 1.25 MG Oral Tablet
Display name
Estrogens, conjugated (USP) (Oral Pill)
Full name
estrogens, conjugated (USP) 1.25 MG Oral Tablet
Term type
SCD
Status
Active
Strength
1.25 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-11-06 11:39:43

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042005
Active start
042005
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
estrogens, conjugated (USP)1.25 MG / 1 EACHestrogens, conjugated (USP)estrogens, conjugated (USP)

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
estrogens, conjugated (USP)4099

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRestrogens, conjugated (USP) 1.25 MG Oral Tablet1NAMES
RxNorm Nameestrogens, conjugated (USP) 1.25 MG Oral Tablet1NAMES
TTYSCD1ATTRIBUTES
SPL_SET_ID
2 linked values
2CODES
RxCUI1976621CODES
MMSL_CODE
2 linked values
2CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
50742-391-0150742-391estrogens, conjugated estrogens, conjugatedIngenus Pharmaceuticals, LLCANDA214023
50742-391-1050742-391estrogens, conjugated estrogens, conjugatedIngenus Pharmaceuticals, LLCANDA214023
66993-299-0266993-299Conjugated Estrogens estrogens, conjugatedPrasco LaboratoriesNDA004782

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA21402350742-391estrogens, conjugated estrogens, conjugatedANDAIngenus Pharmaceuticals, LLC
NDA00478266993-299Conjugated Estrogens estrogens, conjugatedNDA AUTHORIZED GENERICPrasco Laboratories

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 2 of 2 · 187 matching rows.

NDC11, Source, Active table
NDC11SourceActive
53918019007rxnav_historical
53918019009rxnav_historical
53978006210rxnav_historical
53978019009rxnav_historical
54269012501rxnav_historical
54421012101rxnav_historical
54441009301rxnav_historical
54441009305rxnav_historical
54441009310rxnav_historical
54441009325rxnav_historical
54441009350rxnav_historical
54569081300rxnav_historical
54569081301rxnav_historical
54569081350rxnav_historical
54569801400rxnav_historical
54569850500rxnav_historical
54569850501rxnav_historical
54569850502rxnav_historical
54868045300rxnav_historical
54868045301rxnav_historical
54868045302rxnav_historical
54868045303rxnav_historical
54868045304rxnav_historical
54868045305rxnav_historical
54868045306rxnav_historical
55045195101rxnav_historical
55045195108rxnav_historical
55154021101rxnav_historical
55289004725rxnav_historical
55289004730rxnav_historical
55289004742rxnav_historical
55289004790rxnav_historical
57866668201rxnav_historical
57866668202rxnav_historical
58016098300rxnav_historical
58016098312rxnav_historical
58016098314rxnav_historical
58016098315rxnav_historical
58016098320rxnav_historical
58016098330rxnav_historical
58056016110rxnav_historical
58056016181rxnav_historical
58087001375rxnav_historical
60491051625rxnav_historical
60491051630rxnav_historical
60491051634rxnav_historical
60491051690rxnav_historical
62584086600rxnav_historical
62584086690rxnav_historical
65084017910rxnav_historical
65084017912rxnav_historical
66105013810rxnav_historical
66267024707rxnav_historical
66267024710rxnav_historical
66267024715rxnav_historical
66267024720rxnav_historical
66267024730rxnav_historical
67228012003rxnav_historical
67228012006rxnav_historical
67801032703rxnav_historical
67801042703rxnav_historical
67801042730rxnav_historical
68115029430rxnav_historical
68258908901rxnav_historical
68788086603rxnav_historical
68788086606rxnav_historical
68788086609rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
estrogens, conjugatedESTROGENS, CONJUGATEDIngenus Pharmaceuticals, LLC7277bab4-d8c2-4e4b-a0d9-5dfe1885d5472026-08-25Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 50742-391-10
ndc (package): 50742-391-01
ndc (product): 50742-391
ndc11 (package): 50742039110
ndc11 (package): 50742039101
rxcui: 197662
PremarinESTROGENS, CONJUGATEDWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.258e1602-a3cf-4ccc-ca80-73dbbfb812ff2026-06-04Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 197662
Conjugated EstrogensESTROGENS, CONJUGATEDPrasco Laboratoriesce793f9e-0c20-43e6-9dc0-064e5c82e2432026-02-27Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 66993-299-02
ndc (product): 66993-299
ndc11 (package): 66993029902
rxcui: 197662

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b32fcb1b-fee4-44b8-a91c-10dfdd3f84eaestrogens, conjugated 1.25 MG Oral Tablet [PSN] · estrogens, conjugated (USP) 1.25 MG Oral Tablet [SCD]2320140508
ce793f9e-0c20-43e6-9dc0-064e5c82e243estrogens, conjugated 1.25 MG Oral Tablet [PSN] · estrogens, conjugated (USP) 1.25 MG Oral Tablet [SCD]21These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. Conjugated Estrogens Tablets, for oral use Initial U.S. Approval: 194220260227
7277bab4-d8c2-4e4b-a0d9-5dfe1885d547estrogens, conjugated 1.25 MG Oral Tablet [PSN] · estrogens, conjugated (USP) 1.25 MG Oral Tablet [SCD]21These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 194220251016

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
7277bab4-d8c2-4e4b-a0d9-5dfe1885d547These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 1942Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd.20260825
258e1602-a3cf-4ccc-ca80-73dbbfb812ffThese highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company20260604
ce793f9e-0c20-43e6-9dc0-064e5c82e243These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. Conjugated Estrogens Tablets, for oral use Initial U.S. Approval: 1942Prasco Laboratories | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company20260227
258e1602-a3cf-4ccc-ca80-73dbbfb812ffThese highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company20260220
7277bab4-d8c2-4e4b-a0d9-5dfe1885d547These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 1942Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd.20251016
43194b78-d140-4ce0-a7c0-1690a1950bcbThese highlights do not include all the information needed to use LAMOTRIGINE TABLETS and LAMOTRIGINE TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS and LAMOTRIGINE TABLETS FOR ORAL SUSPENSION. LAMOTRIGINE tablets, for oral use LAMOTRIGINE tablets for oral suspension (chewable, dispersible tablets) Initial U.S. Approval: 1994McKesson Corporation dba RX Pak20210210
b32fcb1b-fee4-44b8-a91c-10dfdd3f84eaPhysicians Total Care, Inc.20140508
045e5620-93ba-4999-9077-0ceb7d44f25aNational Council for Prescription Drug Programs20120724
15730b27-2ca3-40e0-a916-b9782559f05fNational Council for Prescription Drug Programs20120724
834f329c-0b47-4746-b845-de52f39d1aa5National Council for Prescription Drug Programs20120724
8d28483d-179a-4844-82b6-6beb3f7ab047National Council for Prescription Drug Programs20120724
a26ec858-dd5a-45d3-a3d6-b59aa53bf05bNational Council for Prescription Drug Programs20120724
d1a77d1a-e412-479a-917c-ce5993afdae3National Council for Prescription Drug Programs20120724
e9e29325-60f7-4c60-8979-b710d8702b93National Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCG03CANatural and semisynthetic estrogens, plainATC1-4estrogens, conjugated (USP)
FDASPLD004966Estrogens, Conjugated (USP)CHEMhas_chemical_structureestrogens, conjugated (USP)
FDASPLN0000175825EstrogenEPChas_epcestrogens, conjugated (USP)
FDASPLN0000000100Estrogen Receptor AgonistsMOAhas_moaestrogens, conjugated (USP)
MEDRTD004966Estrogens, Conjugated (USP)CHEMhas_ingredientestrogens, conjugated (USP)
MEDRTD020152Antithrombin III DeficiencyDISEASEci_withestrogens, conjugated (USP)
MEDRTD001943Breast NeoplasmsDISEASEmay_treatestrogens, conjugated (USP)
MEDRTD001943Breast NeoplasmsDISEASEci_withestrogens, conjugated (USP)
MEDRTD004342Drug HypersensitivityDISEASEci_withestrogens, conjugated (USP)
MEDRTD006470HemorrhageDISEASEci_withestrogens, conjugated (USP)
MEDRTD019584Hot FlashesDISEASEmay_treatestrogens, conjugated (USP)
MEDRTD007006HypogonadismDISEASEmay_treatestrogens, conjugated (USP)
MEDRTD008107Liver DiseasesDISEASEci_withestrogens, conjugated (USP)
MEDRTD008594Menopause, PrematureDISEASEmay_treatestrogens, conjugated (USP)
MEDRTD008595MenorrhagiaDISEASEmay_treatestrogens, conjugated (USP)
MEDRTD009376Neoplasms, Hormone-DependentDISEASEci_withestrogens, conjugated (USP)
MEDRTD015663Osteoporosis, PostmenopausalDISEASEmay_preventestrogens, conjugated (USP)
MEDRTD011247PregnancyDISEASEci_withestrogens, conjugated (USP)
MEDRTD016649Primary Ovarian InsufficiencyDISEASEmay_treatestrogens, conjugated (USP)
MEDRTD011471Prostatic NeoplasmsDISEASEmay_treatestrogens, conjugated (USP)
MEDRTD011655Pulmonary EmbolismDISEASEci_withestrogens, conjugated (USP)
MEDRTD013923ThromboembolismDISEASEci_withestrogens, conjugated (USP)
MEDRTD013924ThrombophlebitisDISEASEci_withestrogens, conjugated (USP)
MEDRTD020246Venous ThrombosisDISEASEci_withestrogens, conjugated (USP)
MEDRTN0000000100Estrogen Receptor AgonistsMOAhas_moaestrogens, conjugated (USP)
MEDRTN0000008311Bone Formation StimulationPEhas_peestrogens, conjugated (USP)
MEDRTN0000009051Gonadotropin Releasing Hormone AlterationPEhas_peestrogens, conjugated (USP)
MEDRTN0000009065Hematologic Activity AlterationPEci_peestrogens, conjugated (USP)
MEDRTN0000009805Pituitary Gland Activity AlterationPEhas_peestrogens, conjugated (USP)
MEDRTN0000009902Vaginal Function AlterationPEhas_peestrogens, conjugated (USP)
MEDRTN0000000026Hepatic MetabolismPKhas_pkestrogens, conjugated (USP)
MEDRTN0000000042Renal ExcretionPKhas_pkestrogens, conjugated (USP)

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH1.25 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA214023
CODESSNOMEDCT325557008
CODESVUID4004637
CODESVUID4016497
NAMESPrescribable Synonymestrogens, conjugated 1.25 MG Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File